Growing prevalence of Providencia stuartii associated with the increased usage of colistin at a tertiary health care center

International Journal of Infectious Diseases

Volumn 16, Issue 9, 2012, Pages

  Hayakawa, Kayoko ^a   Marchaim, Dror ^a   Divine, George W ^b   Pogue, Jason M ^c   Kumar, Sarwan ^a   Lephart, Paul ^c   Risko, Ken ^c   Sobel, Jack D ^a   Kaye, Keith S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c DETROIT MEDICAL CENTER   (United States)

Author keywords

Antimicrobial resistance; Colistin; Gram negative bacteria; Providencia stuartii; Tigecycline

Indexed keywords

COLISTIN; TIGECYCLINE;

ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BACTERIAL LOAD; MEDICAL RECORD REVIEW; NONHUMAN; PROVIDENCIA STUARTII; RETROSPECTIVE STUDY; SHORT SURVEY; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; LOGISTIC MODELS; MICHIGAN; MIDDLE AGED; MINOCYCLINE; PREVALENCE; PROVIDENCIA; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84865550651     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.05.1029     Document Type: Short Survey

References (10)

1. Kim B.N., Kim N.J., Kim M.N., Kim Y.S., Woo J.H., Ryu J. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis 2003, 35:98-103.
2. Robin F., Aggoune-Khinache N., Delmas J., Naim M., Bonnet R. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother 2010, 54:466-470.
3. Reddy T., Chopra T., Marchaim D., Pogue J.M., Alangaden G., Salimnia H., et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother 2010, 54:2235-2238.
4. Marchaim D., Chopra T., Perez F., Hayakawa K., Lephart P.R., Bheemreddy S., et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol 2011, 32:861-871.
5. Rose W.E., Rybak M.J. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy 2006, 26:1099-1110.
6. Li J., Nation R.L., Milne R.W., Turnidge J.D., Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005, 25:11-25.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Approved standard M100-S19. Wayne, PA: CLSI; 2009.
8. Aschbacher R., Pagani L., Doumith M., Pike R., Woodford N., Spoladore G., et al. Metallo-beta-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary care hospital and long-term care facilities during 2008. Clin Microbiol Infect 2010.
9. Tsakris A., Ikonomidis A., Poulou A., Spanakis N., Pournaras S., Markou F. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 2007, 60:136-139.
10. Tsakris A., Ikonomidis A., Spanakis N., Poulou A., Pournaras S. Characterization of In3Mor, a new integron carrying VIM-1 metallo-beta-lactamase and sat1 gene, from Morganella morganii. J Antimicrob Chemother 2007, 59:739-741.